Search research articles
Contact Us
Filters
Showing results (61-70 of 416) with videos related to
Page
of 42
Sort By:
Cancers
|
January 20, 2018
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Fabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
January 1, 2013
Castration resistant prostate cancer (CRPC): state of the art, perspectives and new challenges
Francesco Massari, Francesca Maines, Alessandra Modena, et al.
Breast Cancer Research and Treatment
|
April 15, 2005
Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer
Gianluigi Ferretti, Mario Mandalà, Emilio Bria, et al.
Journal of Thoracic Disease
|
June 28, 2019
Exploring the molecular and biological background of lung neuroendocrine tumours
Michele Simbolo, Vincenzo Di Noia, Ettore D'Argento, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 15, 2010
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study
Antonio Rozzi, Chiara Nardoni, Michela Corona, et al.
Ebiomedicine
|
October 2, 2015
Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening
Rafael Rosell, Niki Karachaliou, Imane Chaib, et al.
Targeted Oncology
|
January 29, 2013
Clinical meta-analyses of targeted therapies in adenocarcinoma
Emilio Bria, Maria Bonomi, Sara Pilotto, et al.
Cancer Treatment Reviews
|
March 26, 2017
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition
Francesco Facchinetti, Giulio Rossi, Emilio Bria, et al.
Anti-Cancer Drugs
|
November 21, 2012
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors
Massimo Di Maio, Emilio Bria, Giuseppe L Banna, et al.
Expert Opinion on Biological Therapy
|
August 5, 2018
Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies
Vincenzo di Noia, Ettore D'Argento, Sara Pilotto, et al.
Page
of 42
Search research articles
Search
Showing results (61-70 of 416) with videos related to
Sort By:
Page
of 42
Cancers
|
January 20, 2018
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Fabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
January 1, 2013
Castration resistant prostate cancer (CRPC): state of the art, perspectives and new challenges
Francesco Massari, Francesca Maines, Alessandra Modena, et al.
Breast Cancer Research and Treatment
|
April 15, 2005
Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer
Gianluigi Ferretti, Mario Mandalà, Emilio Bria, et al.
Journal of Thoracic Disease
|
June 28, 2019
Exploring the molecular and biological background of lung neuroendocrine tumours
Michele Simbolo, Vincenzo Di Noia, Ettore D'Argento, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 15, 2010
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study
Antonio Rozzi, Chiara Nardoni, Michela Corona, et al.
Ebiomedicine
|
October 2, 2015
Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening
Rafael Rosell, Niki Karachaliou, Imane Chaib, et al.
Targeted Oncology
|
January 29, 2013
Clinical meta-analyses of targeted therapies in adenocarcinoma
Emilio Bria, Maria Bonomi, Sara Pilotto, et al.
Cancer Treatment Reviews
|
March 26, 2017
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition
Francesco Facchinetti, Giulio Rossi, Emilio Bria, et al.
Anti-Cancer Drugs
|
November 21, 2012
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors
Massimo Di Maio, Emilio Bria, Giuseppe L Banna, et al.
Expert Opinion on Biological Therapy
|
August 5, 2018
Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies
Vincenzo di Noia, Ettore D'Argento, Sara Pilotto, et al.
Page
of 42